Legal Entity
Insights
LONGRUNN MEDICAL TECHNOLOGIES PTE. LTD.
Last Updated: 17 Jun 2026
Longrunn Medical Technologies PTE develops and commercializes patented, medical‑grade natural supplements and mycelial fermentation products to prevent and treat diabetes and support organ function. Its flagship proprietary ingredient EFILA — produced through long-term fermentation of select fungal strains (including Ceriporia lacerata K1, Ganoderma applanatum and Irpex lacteus) — is internationally patented and approved for use in health supplements and traditional medicines by the Singapore HSA and certified by Korean authorities. Combining 15–18 years of R&D, specialized fermentation technology, and biopharmaceutical expertise, Longrunn produces products such as BLOOD SUGAR SUPPORT and Longevity that increase pancreatic beta cells, enhance insulin secretion, and aid liver and kidney restoration.
Country of registration | Singapore |
Registration number | 201907466K |
Local SIC | |
Incorporation date | 7 Mar 2019 |
Company age | 7 years 3 months |
Official entity type | Exempt Private Limited Company |
No. of officers | 8 |
Contact
Address:
237 PANDAN LOOP, #08-10, WESTECH BUILDING, Singapore 128424
Access Key Decision Makers
This is the legal entity page of LONGRUNN MEDICAL TECHNOLOGIES PTE. LTD.. To access company info, company size, news , key makers’ emails, visit the profile pages above.
Associated business (1)
- LONGRUNN MEDICAL TECHNOLOGIES PTEView MoreSingaporeLongrunn Medical Technologies PTE develops and commercializes patented, medical‑grade natural supplements and mycelial fermentation products to prevent and treat diabetes and support organ function. Its flagship proprietary ingredient EFILA — produced through long-term fermentation of select fungal strains (including Ceriporia lacerata K1, Ganoderma applanatum and Irpex lacteus) — is internationally patented and approved for use in health supplements and traditional medicines by the Singapore HSA and certified by Korean authorities. Combining 15–18 years of R&D, specialized fermentation technology, and biopharmaceutical expertise, Longrunn produces products such as BLOOD SUGAR SUPPORT and Longevity that increase pancreatic beta cells, enhance insulin secretion, and aid liver and kidney restoration.
This is the legal entity page of LONGRUNN MEDICAL TECHNOLOGIES PTE. LTD.. To access company info, company size, news, key maker's emails, visit the profile pages above.
Financials
Revenue | 1 - 10m |
Share Capital - Ordinary shares | USD 1,000,800 |
Last updated: 17 Jun 2026
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Discover More Companies
Lookalike companies
* This profile contains information from ACRA Information on Corporate Entities from Accounting and Corporate Regulatory Authority which is made available under the terms of the Singapore Open Data Licence version 1.0. Information and datasets on our website are provided on an “as is” and “as available” basis. This website makes no representations or warranties concerning the datasets, including but not limited to any representation or warranty as to the accuracy, completeness, reliability, continued availability, timeliness, non-infringement, title, quality, or fitness for any particular purpose of the datasets to the fullest extent permitted by the law.
Frequently Asked Questions (FAQ)
- What is the address of LONGRUNN MEDICAL TECHNOLOGIES PTE. LTD.?
- Where is LONGRUNN MEDICAL TECHNOLOGIES PTE. LTD.'s headquarter?
- What is LONGRUNN MEDICAL TECHNOLOGIES PTE. LTD.'s contact number?
- What LONGRUNN MEDICAL TECHNOLOGIES PTE. LTD.'s spending power?
- Does LONGRUNN MEDICAL TECHNOLOGIES PTE. LTD. have a presence in the domain it operates in?